Summit Reinsurance Services, Inc., or Summit Re, acts as a reinsurance advisor and managing underwriter for health-related risk. The company supports health insurers and employers by helping them transfer large medical risk.
Summit Re started in 1999 as a focused reinsurance advisor and managing general underwriter. The firm built its name helping clients manage big healthcare risks.
Summit Reinsurance later became a trusted partner to health plans and employers. Many events also helped its growth:
In 2025, Summit Re shared new support for advanced gene therapy and diagnostics in care models. The company continues to handle risk for new healthcare treatments.
Summit Reinsurance helps clients manage large medical risks by offering tailored solutions from its toolbox:
These tools help Summit Re build smart strategies instead of pushing off-the-shelf products. The company stays focused on helping each client manage risk their own way.
Summit Reinsurance builds lasting partnerships by working side by side with clients to manage risk. The company promotes strong relationships over sales, knowing shared success protects everyone’s resources. It also focuses on:
These values build trust and focus on lasting partnerships, not short-term targets.
The firm expects every partner to follow its standards and act with fairness and care. Trust grows when business is done right. They also give importance to:
Anyone representing Summit Reinsurance is expected to meet these standards at all times. These values apply to every producer, partner, and team working on its behalf.
Summit Reinsurance stays active in healthcare risk by working with key industry groups and alliances:
These partnerships help shape standards and support smarter use of reinsurance tools in healthcare.
Summit Reinsurance takes a hands-on approach built around goals and deep understanding. The team responds quickly, follows through on promises, and supports clients with practical solutions. Every move aims to strengthen partnerships and manage risk with care.
SVP Brian Fehlhaber, one of Summit Re’s founders, retired in early 2025. He led reinsurance sales and shaped the company’s direction with a hands-on, consultative style. The company continues to move forward with a strong team and a clear direction in place.
Summit Reinsurance shared a 2025 report on gene therapy from a reinsurance and stop loss view. It covered trends in costly treatments like Zolgensma, Elevidys, and Lenmeldy. The company tracks these shifts to guide smarter risk planning for rare, high-cost claims.
Specialists discuss modeling gaps and prevention strategies
Bumper returns built on discipline are meeting a new reality
Organizers say environmental risk, capital strategy, and regulation can no longer be discussed in separate rooms
Record capital levels, softening rates, and the rise of ILS have fundamentally changed the math
400+ delegates from 17 countries will hear about the industry's "rapid change" phase